bazedoxifene has been researched along with Atrophy in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 11 (91.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, L; Bushmakin, AG; Komm, BS; Pinkerton, JV | 1 |
| Conner, EA; Pinkerton, JV | 1 |
| Pinkerton, JV; Stanczyk, FZ | 1 |
| Komm, BS; Mirkin, S; Pinkerton, JV | 1 |
| Raney, EC | 1 |
| Arias, L; Komm, BS; Lavenberg, J; Mirkin, S; Palacios, S; Pan, K | 1 |
| Crider, M; Hill, DA; Hill, SR | 1 |
| Constantine, G; Dorin, MH; Gass, MLS; Lobo, RA; Pickar, JH; Pinkerton, JV; Ronkin, S | 1 |
| Kagan, R; Mirkin, S; Pan, K; Pickar, JH; Williams, RS | 1 |
| Bachmann, G; Bobula, J; Mirkin, S | 1 |
| Levine, JP | 1 |
| Mirkin, S; Pickar, JH; Pinkerton, JV; Racketa, J | 1 |
6 review(s) available for bazedoxifene and Atrophy
| Article | Year |
|---|---|
Beyond estrogen: advances in tissue selective estrogen complexes and selective estrogen receptor modulators.
Topics: Adult; Aged; Atrophy; Breast Neoplasms; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Hot Flashes; Humans; Indoles; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina | 2019 |
Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy.
Topics: Atrophy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Pelvic Organ Prolapse; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Treatment Outcome; Vagina; Vaginal Diseases; Vulva; Vulvar Diseases | 2014 |
Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model.
Topics: Animals; Atrophy; Estrogens, Conjugated (USP); Female; Gene Expression; Hot Flashes; Humans; Indoles; Lipid Metabolism; Osteoporosis, Postmenopausal; Quality of Life; Selective Estrogen Receptor Modulators; Sleep; Vagina; Venous Thromboembolism; Vulva | 2013 |
Hormone Therapy and Other Treatments for Symptoms of Menopause.
Topics: Acupuncture Therapy; Administration, Intravaginal; Amines; Antidepressive Agents; Atrophy; Cyclohexanecarboxylic Acids; Dietary Supplements; Drug Therapy, Combination; Dyspareunia; Estrogen Replacement Therapy; Estrogens; Exercise Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Hypnosis; Indoles; Menopause; Paroxetine; Progestins; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina; Vaginal Diseases; Vasomotor System; Venlafaxine Hydrochloride | 2016 |
Treating menopausal symptoms with a tissue-selective estrogen complex.
Topics: Atrophy; Body Mass Index; Climacteric; Endometrial Hyperplasia; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Postmenopause; Quality of Life; Selective Estrogen Receptor Modulators; Vagina; Vasomotor System; Vulva; Women's Health | 2011 |
Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.
Topics: Adult; Aged; Atrophy; Clinical Trials, Phase III as Topic; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis; Quality of Life; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Treatment Outcome; Vagina; Vaginal Diseases; Vulva | 2012 |
5 trial(s) available for bazedoxifene and Atrophy
| Article | Year |
|---|---|
Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning.
Topics: Adult; Aged; Atrophy; Coitus; Double-Blind Method; Female; Humans; Indoles; Middle Aged; Pain; Postmenopause; Pruritus; Quality of Life; Selective Estrogen Receptor Modulators; Sexual Dysfunction, Physiological; Vagina; Vaginal Diseases; Vulva | 2017 |
Evaluation of efficacy and safety of conjugated estrogens/bazedoxifene in a Latin American population.
Topics: Adult; Aged; Atrophy; Body Mass Index; Bone Density; Double-Blind Method; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Latin America; Middle Aged; Placebos; Postmenopause; Selective Estrogen Receptor Modulators; Vagina; Vulva | 2016 |
Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile.
Topics: Adult; Aged; Atrophy; Carbohydrate Metabolism; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Homocysteine; Hot Flashes; Humans; Indoles; Lipid Metabolism; Menopause; Middle Aged; Outpatients; Selective Estrogen Receptor Modulators; Treatment Outcome; Vagina | 2009 |
A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
Topics: Administration, Intravaginal; Adult; Aged; Atrophy; Double-Blind Method; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Middle Aged; Postmenopause; Treatment Outcome; Vagina; Vaginal Diseases; Vulva | 2010 |
Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy.
Topics: Administration, Intravaginal; Atrophy; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Indoles; Middle Aged; Postmenopause; Quality of Life; Selective Estrogen Receptor Modulators; Sexual Behavior; Treatment Outcome; Vagina; Vaginal Diseases; Vulva | 2010 |
1 other study(ies) available for bazedoxifene and Atrophy
| Article | Year |
|---|---|
What new therapeutic options exist for the relief of menopausal symptoms?
Topics: Atrophy; Bone Density; Female; Hot Flashes; Humans; Indoles; Middle Aged; Postmenopause; Selective Estrogen Receptor Modulators; Tamoxifen; Vaginal Diseases; Vulvar Diseases | 2015 |